Stay updated on Nebulized RNS60 for ALS Clinical Trial
Sign up to get notified when there's something new on the Nebulized RNS60 for ALS Clinical Trial page.

Latest updates to the Nebulized RNS60 for ALS Clinical Trial page
- Check3 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check25 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check46 days agoChange DetectedThe webpage has added important information regarding a clinical trial for nebulized RNS60 aimed at treating Amyotrophic Lateral Sclerosis, including details about the sponsor, Revalesio Corporation, and the trial's ClinicalTrials.gov ID.SummaryDifference25%
- Check53 days agoChange DetectedThe webpage has removed significant information regarding a clinical trial for nebulized RNS60 for the treatment of Amyotrophic Lateral Sclerosis, including details about the sponsor and the study's recruitment status.SummaryDifference20%
- Check68 days agoChange DetectedThe web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content. The phrase 'Here’s how you know' has been modified to 'Here's how you know', which does not significantly alter the core content.SummaryDifference1.0%
Stay in the know with updates to Nebulized RNS60 for ALS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nebulized RNS60 for ALS Clinical Trial page.